Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Neuromuscular Disorders : NMD
|
April 25, 2020
"Status myotonicus" in Na<sub>v</sub>1.4-M1592V channelopathy
Torge Rempe, S H Subramony
Magnetic Resonance Imaging Clinics of North America
|
March 30, 2024
Multiple Sclerosis: Clinical Update and Clinically-Oriented Radiologic Reporting
Phuong Nguyen, Torge Rempe, Reza Forghani
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
March 27, 2026
Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis
Mahmoud Elkhooly, Rhea Jacob, Torge Rempe
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
October 8, 2020
Anti-JCV antibody index does not change during ocrelizumab-treatment
Torge Rempe, Aaron Carlson, Augusto Miravalle, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
February 15, 2019
Dorsal Root Ganglion Stimulation as a Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy: A Retrospective Case Series
Kwo Wei David Ho, Torge Rempe, Nivedita Jerath, et al.
Plos One
|
May 6, 2016
Sensitization of the Nociceptive System in Complex Regional Pain Syndrome
Maren Reimer, Torge Rempe, Carolina Diedrichs, et al.
Bioengineering (Basel, Switzerland)
|
September 27, 2025
Feasibility and Preliminary Efficacy of Wearable Focal Vibration Therapy on Gait and Mobility in People with Multiple Sclerosis: A Pilot Study
Hongwu Wang, Yun Chan Shin, Nicole J Tester, et al.
Multiple Sclerosis and Related Disorders
|
September 14, 2025
Baló's concentric sclerosis: A retrospective case series
Henry Peraza, John Rees, Jesse Kresak, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
May 11, 2026
Factors associated with delays in multiple sclerosis disease-modifying therapy initiation
Laura Snider, Elsa Rodriguez, Hannah Rains, et al.
Multiple Sclerosis and Related Disorders
|
October 9, 2023
Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing - similar clinical efficacy with decreased immunoglobulin M deficiency rates
Torge Rempe, Aisha Elfasi, Elsa Rodriguez, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Neuromuscular Disorders : NMD
|
April 25, 2020
"Status myotonicus" in Na<sub>v</sub>1.4-M1592V channelopathy
Torge Rempe, S H Subramony
Magnetic Resonance Imaging Clinics of North America
|
March 30, 2024
Multiple Sclerosis: Clinical Update and Clinically-Oriented Radiologic Reporting
Phuong Nguyen, Torge Rempe, Reza Forghani
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
March 27, 2026
Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis
Mahmoud Elkhooly, Rhea Jacob, Torge Rempe
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
October 8, 2020
Anti-JCV antibody index does not change during ocrelizumab-treatment
Torge Rempe, Aaron Carlson, Augusto Miravalle, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
February 15, 2019
Dorsal Root Ganglion Stimulation as a Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy: A Retrospective Case Series
Kwo Wei David Ho, Torge Rempe, Nivedita Jerath, et al.
Plos One
|
May 6, 2016
Sensitization of the Nociceptive System in Complex Regional Pain Syndrome
Maren Reimer, Torge Rempe, Carolina Diedrichs, et al.
Bioengineering (Basel, Switzerland)
|
September 27, 2025
Feasibility and Preliminary Efficacy of Wearable Focal Vibration Therapy on Gait and Mobility in People with Multiple Sclerosis: A Pilot Study
Hongwu Wang, Yun Chan Shin, Nicole J Tester, et al.
Multiple Sclerosis and Related Disorders
|
September 14, 2025
Baló's concentric sclerosis: A retrospective case series
Henry Peraza, John Rees, Jesse Kresak, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
May 11, 2026
Factors associated with delays in multiple sclerosis disease-modifying therapy initiation
Laura Snider, Elsa Rodriguez, Hannah Rains, et al.
Multiple Sclerosis and Related Disorders
|
October 9, 2023
Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing - similar clinical efficacy with decreased immunoglobulin M deficiency rates
Torge Rempe, Aisha Elfasi, Elsa Rodriguez, et al.
Page
of 4